Investigation into solid and solution properties of quinizarin by Cheuk, Dominic et al.
CrystEngComm
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
1 
A
pr
il 
20
15
. D
ow
nl
oa
de
d 
on
 2
1/
10
/2
01
6 
22
:4
9:
01
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.PAPER View Article OnlineView Journal  | View IssueCrystEngCommThis journal is © The Royal Society of Chemistry 2015
a Synthesis and Solid State Pharmaceutical Centre, Materials and Surface Science
Institute, Department of Chemical and Environmental Sciences, University of
Limerick, Limerick, Ireland. E-mail: ake.rasmuson@ul.ie
b Department of Chemical Engineering and Technology, KTH Royal Institute of
Technology, Stockholm, Sweden
c Chemistry and Forensic Science, University of Bradford, Bradford, UK
d School of Chemistry, National University of Ireland Galway, University Road,
Galway, Ireland
† Electronic supplementary information (ESI) available: IR spectra of FI and FII,
crystallographic data of quinizarin FI and FII, hydrogen-bond geometry in the
crystal structures of quinizarin FI and FII. CCDC 1044980 and 1044981. For ESI
and crystallographic data in CIF or other electronic format see DOI: 10.1039/
c5ce00147aCite this: CrystEngComm, 2015, 17,
3985Received 22nd January 2015,
Accepted 21st April 2015
DOI: 10.1039/c5ce00147a
www.rsc.org/crystengcommInvestigation into solid and solution properties of
quinizarin†
Dominic Cheuk,a Michael Svärd,ab Colin Seaton,c Patrick McArdled
and Åke C. Rasmuson*ab
Polymorphism, crystal shape and solubility of 1,4-dihydroxyanthraquinone (quinizarin) have been
investigated in acetic acid, acetone, acetonitrile, n-butanol and toluene. The solubility of FI and FII from 20
°C to 45 °C has been determined by a gravimetric method. By slow evaporation, pure FI was obtained from
n-butanol and toluene, pure FII was obtained from acetone, while either a mixture of the two forms or
pure FI was obtained from acetic acid and acetonitrile. Slurry conversion experiments have established an
enantiotropic relationship between the two polymorphs and that the commercially available FI is actually a
metastable polymorph of quinizarin under ambient conditions. However, in the absence of FII, FI is kineti-
cally stable for many days over the temperature range and in the solvents investigated. FI and FII have been
characterized by infrared spectroscopy (IR), thermogravimetric analysis (TGA), differential scanning calorim-
etry (DSC), scanning electron microscopy (SEM), transmission and ordinary powder X-ray diffraction (PXRD)
at different temperatures. The crystal structure of FII has been determined by single-crystal XRD. DSC and
high-temperature PXRD have shown that both FI and FII will transform into a not previously reported high-
temperature form (FIII) around 185 °C before this form melts at 200–202 °C. By indexing FIII PXRD data, a
triclinic P1¯ cell was assigned to FIII. The solubility of quinizarin FI and FII in the pure organic solvents used
in the present work is below 2.5% by weight and decreases in the order: toluene, acetone, acetic acid, ace-
tonitrile and n-butanol. The crystal shapes obtained in different solvents range from thin rods to flat plates
or very flat leaves, with no clear principal difference observed between FI and FII.Introduction
Crystallization is a key process in the manufacturing of many
organic compounds and of most pharmaceutical com-
pounds.1 The solid–liquid solubility of the compound in dif-
ferent solvents is important information in the planning and
design of the process. In addition, the solubility relationships
carry information about how the solute molecule interacts
with the solvent in solution and is accordingly of value in the
interpretation of the influence of the solvent on nucleation
and crystal growth.2 The crystal shape is of significant impor-
tance for downstream processing and end-use.3 Polymorphismhas been an important topic for 20 years, especially in the
pharmaceutical industry, where there is a requirement to
identify all possible solid forms of a drug and where poly-
morphs can be protected by IP rights.4
Anthraquinones are the most important quinone deriva-
tives of anthracene5 which are known to be present in many
plant families such as Leguminosae, Liliaceae, Polygonaceae,
Rubiaceae, and Rhamnaceae.6 Anthraquinone derivatives
have been widely used as dyes for many years since they can
provide a wide range of colours covering the entire visible
spectrum.7 Anthraquinone derivatives exert a wide range of
biological activities including laxative,8 diuretic,9 antioxidant,10
antifungal,11 antimicrobial and antiviral activities.12 They
have also been used as anticancer agents, e.g. Ametantrone
[64862-96-0] and Mitoxantrone (also known as Novantrone)
ĳ65271-80-9], to treat breast cancer and acute leukemia.
Recently, more and more derivatives have been found to pos-
sess abilities as listed above, especially in the search of novel
or second-generation anti-cancer drugs.13,14
Among the anthraquinones, dihydroxyanthraquinones
constitute the most important group and are largely used as
dyes and in the manufacture of dye intermediates.15,16 They
also form the building blocks of many medicinal drugs.17
1,4-Dihydroxyanthraquinone (quinizarin) (Fig. 1) is used as a, 2015, 17, 3985–3997 | 3985
Fig. 1 Molecular structure of quinizarin.
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View Article Onlinefungicide and pesticide chemical18 and has shown the ability
to inhibit tumour cell growth.19
Two polymorphs of quinizarin (FI and FII) are known, and
FI has been reported as the stable form in the literature.20
Unit cells of both FI and FII have been reported.21 The
full crystal structure of FI has been solved22 (CSD refcode
DHXANT10) and it crystallizes in the monoclinic system,
space group number 14 with one molecule per asymmetric
unit. To date, to the best of our knowledge, no single crystal
data for FII have been reported, and there are no published
solubility data for quinizarin in organic solvents.
In this study, the solubility of both polymorphs in several
pure organic solvents at different temperatures was measured
using a gravimetric method. In crystallization experiments,
different crystal shapes and polymorphic forms were investi-
gated. In slurry conversion experiments, we show that there
is, in fact, an enantiotropic relationship between FI and FII.
In order to gain an understanding of the relationship
between crystal structure and crystal growth, the crystal struc-
ture of FI was re-determined and the structure of FII has
been solved, and in addition, crystals of each polymorph
have been face indexed.
Experimental work
Materials
1,4-Dihydroxyanthraquinone (CAS reg. no. 81-64-1, purity
99.3%, verified to be FI by transmission PXRD) was purchased
from Fluka and used without further purification. FII used in
this work was obtained by slurrying excess FI in acetone at
10 °C. Organic solvents were purchased from Sigma-Aldrich
and used as received: acetic acid (Puriss grade, ≥99.8%), ace-
tone (Chromasolv, ≥99.8%), acetonitrile (Chromasolv plus,
≥99.9%), n-butanol (Chromasolv plus, ≥99.7%) and toluene
(Chromasolv, 99.9%).
Experimental setup
The setup consisted of a thermostatic water bath (Grant
S26 stainless steel water bath; 26 L, 505 × 300 × 200 mm;
equipped with a Grant C2G cooling unit and a Grant GR150
control unit; at 310 K, stability ±0.005 K and uniformity
±0.02 K) with a serial submersible 60 points magnetic stirrer
plate (2Mag) placed on the base and a submersible water
pump (1400 L h−1) to enhance circulation in the bath. The
set temperature was validated by a digital thermometer3986 | CrystEngComm, 2015, 17, 3985–3997(D750 PT, Dostmann electronic, Wertheim, Germany, uncer-
tainty of ±0.01 K).
Thermodynamic and kinetic stability
Mechanical mixtures of solid FI and FII were slurried in the
five organic solvents and at different temperatures from 30 °C
to 80 °C in 10 °C increments, and the sampled solids were
analysed with transmission PXRD. Saturated solutions with
excess FI in different solvents were prepared in 30 mL glass
vials with PTFE-coated magnetic stirrers, at 25 °C, 35 °C and
50 °C, and the solids were sampled and analysed with trans-
mission PXRD after five days and ten days.
Solubility of FI and FII
Solutions with excess pure FI or FII were prepared in 30 mL
glass vials with PTFE-coated magnetic stirrers. The vials
were placed on the magnetic stirrer plate with agitation of
600 rpm in the water bath for at least 18 hours at each tem-
perature to allow equilibrium to be reached. Stirring was then
turned off and excess solids were allowed to settle for two
hours. Clear solution was sampled using syringes (5 mL) and
filtered through syringe filters (PTFE/Nylon, 25 mm, pore size
0.2 μm, VWR) into pre-weighed glass vials. Syringes and fil-
ters were pre-heated to 5 °C above the saturation temperature
to prevent nucleation inside the syringes during sampling.
The weight of each solution was recorded immediately. The
samples were completely dried in a ventilated laboratory
hood at room temperature, and the weight of each sample
was recorded repeatedly throughout the drying process in
order to ensure complete dryness. Finally, the samples were
dried in an oven at 40 °C for six hours to ensure all solvent
had evaporated. At each temperature, the solids in equilib-
rium with the solution were sampled, dried and analysed by
ex situ PXRD in order to ensure that no transformation of the
original solid structure had occurred.
Crystal shape
Slow evaporation crystallisation experiments were performed
in 5 mL scale at room temperature in a ventilated laboratory
hood. The solvent was allowed to evaporate through small
holes in the aluminium foil cover. Cooling crystallisation
experiments were conducted in 30 mL vials filled with
approximately 20 mL solution saturated at 40 °C and agitated
at 600 rpm using magnetic stirrers. Solutions were cooled
instantaneously from 45 °C to either 35 °C or 5 °C. In some
experiments, agitation was suspended immediately upon visi-
ble nucleation. The crystals were sampled twice by filtration,
initially after nucleation occurred and subsequently after five
days under the same conditions. Crystals were analysed using
PXRD and SEM.
Solid-state characterization
Solid samples of quinizarin have been identified and charac-
terized using attenuated total reflection infrared spectroscopyThis journal is © The Royal Society of Chemistry 2015
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View Article Online(ATR-IR, Perkin Elmer Spectrum 100 IR spectrometer with a
Universal ATR sampling accessory), transmission powder
X-ray diffraction (PXRD, PANalytical Empyrean) and variable-
temperature PXRD (PANalytical X'Pert MPD Pro with a hot
stage accessory). Crystal shape analysis has been carried
out using scanning electron microscopy (SEM, JEOL
CarryScope scanning electron microscope JCM-5700). The
thermal behaviour has been investigated using differential
scanning calorimetry (DSC, PerkinElmer Pyris 1) and thermo-
gravimetric analysis (simultaneous DSC-TGA, SDT, Q600, TA
Instruments).
Single-crystal X-ray diffraction
An Oxford Diffraction Xcalibur system was used to collect
X-ray diffraction data. The crystal structures of FI and FII
were solved by direct methods (Shelxs) and refined by full
matrix least-squares using Shelxl-2014 within the Oscail
package.23,24 The crystal structure of FI was refined close to
the orthogonal P21/n setting with a β angle of 95.999Ĳ8)°,
while the structure of FI in the CSD with refcode DHXANT10
was refined in P21/a with an obtuse β angle of 125.46°. It is
preferable to use the more orthogonal cell.25
Results and discussion
Solvent selection and polymorph screening
A common approach for investigating the polymorphic
behaviour of a compound is to perform solution crystalliza-
tions using a range of solvents chosen to have diverse proper-
ties in order to maximise the chances of isolating different
solid forms. Here, a set of five solvents with relatively higher
solubility (predicted using Hansen solubility parameters)This journal is © The Royal Society of Chemistry 2015
Fig. 2 (a) Asymmetric unit of the FI structure (labelled atoms) and its hydrowas selected, having a range of polarities and functional
groups for solution crystallizations. Crystallizations including
slow evaporation, cooling with different cooling rates and
slurry conversion were performed. In addition, DSC and
thermogravimetric analysis were carried out to determine the
thermal behaviour of quinizarin. Three forms of quinizarin
were found, but only FI and FII were obtained under ambient
conditions. FI and FII are enantiotropically related to each
other, and both appear as dark orangey-red plates or needles.Crystal structures of FI and FII
The crystal structure of FI was determined by single-crystal
XRD, using a needle-shaped crystal grown from toluene
solution. In the FI structure, the molecules form intra- and
intermolecular hydrogen bonds leading to the formation of
ribbons (Fig. 2(a)). These ribbons are arranged in slipped
π-stacks which run along the b axis (Fig. 2(b)).
The crystal structure of FII was determined using a
needle-shaped crystal grown from acetic acid solution. The
asymmetric unit containing 8 molecules is shown in Fig. 3(a).
As in the FI structure, the molecules form intra- and inter-
molecular hydrogen bonds leading to the formation of rib-
bons which are stacked along the b axis (Fig. 3(b)).
The structures of FI and FII contain essentially the same
bonding motifs, and the difference between the two crystal
structures is in the packing of the 1-D chains of quinizarin
molecules. FI forms a herringbone packing with alternating
stacks (Fig. 4(a)). In contrast, FII forms a stack of molecules
in alternating layers (Fig. 4(b)). The transformation from FI
to FII involves a reduction in the symmetry of FI in which
eight symmetry-related molecules become independent to
accommodate tiny changes in conformation which allow theCrystEngComm, 2015, 17, 3985–3997 | 3987
gen bond ribbon motif and (b) π-stacking in the FI structure.
Fig. 3 (a) Asymmetric unit of the FII structure and (b) π-stacking in the FII structure.
Fig. 4 (a) View of the herringbone packing of FI, viewed along the b-axis and (b) view of the packing of layers in FII.
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View Article OnlineFII structure to pack better and give a small increase in den-
sity. Crystal structure data and hydrogen bond distances of
both structures are provided in the ESI.†Characterisation of polymorphic forms
Mid-infrared spectra of FI and FII are quite similar, and the
unique regions of these two forms are below 1700 cm−1 and3988 | CrystEngComm, 2015, 17, 3985–3997only slight differences can be spotted at 671, 772–784 and
1176 cm−1. The high similarity in IR spectra was expected
considering the small difference in terms of hydrogen bond-
ing between the two forms. The IR spectrum of the commer-
cial FI is identical to the spectra reported in the literature26,27
and the spectrum has been discussed by Nasrallah et al.28
and Xuan et al.29 IR spectra of FI and FII are provided in
the ESI.†This journal is © The Royal Society of Chemistry 2015
Fig. 5 DSC heating–cooling cycles (10 K min−1) using quinizarin FII as
starting material, indicating the transformations into high-temperature
FIII and the melting of FIII.
Fig. 6 Theoretical PXRD pattern of FI (DHXANT10) along with
experimental PXRD patterns of FI, FII and a mechanical mixture of FI
and FII.
Fig. 7 HT-PXRD showing the high-temperature transformation of FI
into FIII.
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View Article OnlineFig. 5 shows DSC thermograms from two consecutive
heating–cooling cycles with a ramp rate of 10 K·min−1,
starting with FII and FI, respectively. The cycles have been
repeated several times in order to isolate and identify the
polymorphic form at different transformation stages using
PXRD. It can be seen that both FI and FII transformed with
an endothermic peak into a previously unreported high-
temperature stable polymorph (FIII) at 185.8 °C and 189.3 °C,
respectively. FIII started to melt at approximately 200 °C.
Upon cooling, the melt recrystallized around 190 °C followed
by a further transformation into FI below 175 °C. Attempts
made to isolate this high temperature form using different
cooling rates and quenching the DSC pans containing the
melt or FIII in liquid nitrogen have been unsuccessful,
resulting in FI. The determined enthalpy, extrapolated onset
and peak temperature of the observed thermal events, aver-
aged over 6 scans, are given in Table 1.
Transmission PXRD patterns of quinizarin, as shown in
Fig. 6, demonstrate the commercial quinizarin to be pure FI,
with an XRD pattern identical to the theoretical pattern of FI
obtained from the structure DHXANT10. Prominent peak
positions (2θ values) for FI are at 15.65, 17.12, 18.21, 20.97,
23.60, 25.70 and 28.71°, and for FII, they are at 6.0, 15.43,
18.02, 21.47, 23.83, 25.97 and 29.00°.
The endothermic transformation of FI into FIII was con-
firmed to be solid–solid phase transformation by applying
different heating rates (0.2, 2, 10 and 50 K min−1) using DSC.
This transformation was further validated by HT-PXRD,
equipped with a hot stage accessory that was calibrated with
indium. Visual comparison of the HT-PXRD data (Fig. 7) indi-
cates that a new phase appeared at about 176 °C, withThis journal is © The Royal Society of Chemistry 2015
Table 1 DSC data of quinizarin reported with 95% confidence intervals
FI to FIII transformation
T (onset)/°C 185.79 ± 0.57
T (peak)/°C 187.62 ± 0.29
ΔH/kJ·mol−1 6.65 ± 0.058complete conversion by 186 °C. Reduction of diffraction
angles can be observed as the temperature increases, due to
the temperature dependence of lattice constants.
Applying Le Bail analysis using the program GSAS30 on
the FIII PXRD data at 180 °C, it was found that none of the
known unit cells (FI, FII from CSD and our determined struc-
tures) give a satisfactory fit to the experimental data. There-
fore the obtained peak positions were used as the basis of
indexing attempt using the range of indexing programs avail-
able in the CMPR program.31 Only the ITO indexing program32
located a suitable cell (a = 4.2846 Å, b = 10.1957 Å, c = 15.3383 Å,
α = 88.6360°, β = 83.2210°, γ = 78.3660°, V = 651.69 Å3). While
this displays a figure of merit lower than those normally
considered correct (M20 = 5.4), it does match all the peaks
in the pattern, and the cell parameters and volume areCrystEngComm, 2015, 17, 3985–3997 | 3989
FII to FIII transformation Melting of FIII
189.32 ± 0.30 200.00 ± 0.67
191.64 ± 0.35 202.97 ± 0.19
6.81 ± 0.074 19.41 ± 0.14
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View Article Onlineconsistent with a molecule of this size (2 molecules in the
unit cell assuming 18 Å3 for each non-H atom). Therefore a
Le Bail analysis was attempted in P1¯ for this cell to confirm
the match of the cell to experimental data. This was success-
fully carried out (Rwp = 7.75%, Rp = 5.60%, χ
2 = 8.727, Fig. 8).
A comparison of the three structures is shown in Table 2.
The metric values of the unit cell are similar to the FII cell
reported in the CSD (a = 14.80 Å, b = 9.49 Å, c = 3.77 Å, α =
90°, β = 93.0°, γ = 90°); however, this cell cannot be refined to
fit the data as well as the indexed triclinic cell and so we
believe the triclinic cell to be the correct high-temperature
cell. This phase, reported as FII in the previous work by
Borgen in 1966 (ref. 21), was different from our experimental
FII and was obtained from slow cooling of the melt in which
some crystals reverted to FI at room temperature. Thus this
cell may refer to another high-temperature polymorph of
quinizarin.Influence of solvent on polymorph and crystal shape
Quinizarin crystals obtained from the five organic solvents by
slow evaporation at room temperature exhibit differences in3990 | CrystEngComm, 2015, 17, 3985–3997
Fig. 8 Final Le Bail fit to PXRD data of FIII at 180 °C.
Table 2 Comparison of unit cell data for FI, FII and FIII data predicted by
Le Bail analysis
FI FII
Predicted
FIII
Crystal system Monoclinic Monoclinic Triclinic
Space group P21/n Cc P1¯
Unit cell
dimensions
a = 10.2390(8) Å a = 20.0099Ĳ12) Å a = 4.2846 Å
b = 6.0429(4) Å b = 24.6219(9) Å b = 10.1957 Å
c = 16.454(2) Å c = 18.3201Ĳ11) Å c = 15.3383 Å
α = 90° α = 90° α = 88.6360°
β = 95.999Ĳ8)°. β = 116.274Ĳ8)° β = 83.221°
γ = 90° γ = 90° γ = 78.366°
Unit cell volume 1012.51Ĳ17) Å3 8093.4(9) Å3 651.69 Å3
Z 4 32 2
Z′ 1 8 1
Density
(calculated)
1.576 Mg m−3 1.577 Mg m−3 1.22 Mg m−3shape and polymorphic form. Recrystallization by slow
evaporation at room temperature from acetone solution con-
sistently produced pure FII, while pure FI was always
obtained from n-butanol and toluene solutions. In samples
obtained from acetic acid and acetonitrile solution, a
mechanical mixture of FI and FII was often found. In cooling
crystallizations from 40 °C to 35 °C, FI was always obtained
from all different solvents. However, with a higher cooling
temperature range from 40 °C to 5 °C in acetone, either pure
FII or a mechanical mixture of FI and FII was obtained.
Thermogravimetric analysis of the solid samples obtained
from the five solvents all show a one-step decomposition pro-
cess between 200 and 300 °C, suggesting that no solvates
were formed.
Some of the crystal habits observed by SEM are shown in
Fig. 9–11. By slow evaporation, thin plates were obtained
from acetic acid and acetonitrile solutions, rods from ace-
tone and toluene solutions, while a leaf-shaped habit was
obtained from n-butanol (Fig. 9). In cooling crystallization
(ΔT = 5 °C), quinizarin mainly crystallizes as plates or prisms
(Fig. 10) but as needles in toluene solution when no agita-
tion was used (Fig. 10(f)). Moreover, with a higher driving
force (ΔT = 35 °C) in acetone (Fig. 11), quinizarin crystallizes
as very thin plates and the morphology is undistinguishable
between the two forms. From observation, quinizarin gener-
ally crystallizes as plates and needles and often seen mixed
together without any tendency of the solvent effects. How-
ever, we can see that the needle growth is favoured without
agitation and a high driving force will yield very thin plate
crystals.
A prediction of the crystal morphology of FI in vacuo was
obtained using the attachment energy method.33 These calcu-
lations assume that the growth rates of different faces are
based only on the energy released in forming the lattice and
that kinetic factors including solvent effects make no contri-
bution. Calculations were carried out using the Morphology
module of Materials Studio 7.0 (Accelrys), with the pcff force
field34 and force field-specific point charges. Fig. 12 shows
the resulting crystal shape, with Miller indices of visible
faces. FI is predicted to favour a plate-like habit, elongated in
the b-direction, dominated by the two {002} faces with the
lowest attachment energy, followed by the two {101} faces.
The predicted habit is more prismatic than observed experi-
mentally, which emphasizes that kinetic factors can domi-
nate crystal growth from solution.
Using single-crystal XRD, the main visible faces of a
needle-shaped crystal of FI grown from toluene solution were
indexed (Fig. 13). The needle growth direction in the FI crys-
tal structure is along the b axis, as predicted, coinciding with
the direction of π-stacking of ribbons. The planes defined by
the ribbons are 3.35 Å apart with the atoms of adjacent
ribbons in van der Waals contact and this is typical of
slipped π-stacked systems and similar to the packing in
β-phthalocyanine and benzoic acid.35 The high growth rate in
the needle direction of β-phthalocyanine has been associated
with the low activation energy required to generate a newThis journal is © The Royal Society of Chemistry 2015
Fig. 9 Crystals recrystallized by slow evaporation in (a) acetic acid (mix of FI and FII), (b) acetone (FII), (c) acetonitrile (mix of FI and FII), (d)
n-butanol (FI) and (e) toluene (FI).
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View Article Onlinestep in the stacking direction.36 The importance of the
crystallization driving force in controlling needle growth in
the gas phase for flat molecule stacked systems has also been
demonstrated.37
Notably, in the present case, when agitation was suspended
upon nucleation needles were observed (Fig. 10(f)), whereas
if agitation continued after nucleation the crystals became
more blocky. The possibility of this being the result of crystal
breakage due to agitation was ruled out based on visual
observation. Without agitation, the effective supersaturation
is expected to decrease locally and thus result in a reduced
crystallization driving force close to the growing crystal sur-
face, favouring needle growth.35 It might appear surprising
that this system in solution mimics the behaviour of other
flat molecule systems in the gas phase. However, toluene is
not a hydrogen bonding solvent and would not be expected
to exert a direct influence on the crystal growth.This journal is © The Royal Society of Chemistry 2015Face-indexed crystals of FII grown from acetic acid without
agitation are shown in Fig. 14. The crystals are initially
needle-like (Fig. 14(a)) but with time gradually take on a
more isotropic shape (Fig. 14(b)). The needles show extended
growth in directions normal to the {101} faces. In the more
prismatic crystals which develop after some time the {10−1}
faces are dominant. It is clear that unlike FI growth in tolu-
ene, FII growth in acetic acid solution is not controlled by
stacking effects. Here solvent hydrogen bonding to growing
crystal faces seems to be more important.
If the packing at the {101}, {010} and {10−1} faces are com-
pared (Fig. 15), it is clear that the hydrogen bonding solvent
will bind more strongly to the latter faces which have a
higher concentration of exposed O atoms and OH groups.
The solvent molecules would be expected to bind least
strongly to the {101} faces as they are dominated by surface
CH groups and it is reasonable that its growth is initiallyCrystEngComm, 2015, 17, 3985–3997 | 3991
Fig. 10 FI recrystallized by cooling (ΔT = 5 °C) in (a) acetic acid, (b) acetone, (c) acetonitrile, (d) n-butanol, (e) toluene with agitation and (f) toluene
without agitation.
Fig. 11 (a) Mixture of FI and FII and (b) pure FII obtained by fast cooling (ΔT = 35°C) in acetone.
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View Article Onlinefaster. It is also reasonable that the {10−1} faces are the ones
which eventually become dominant as they provide the3992 | CrystEngComm, 2015, 17, 3985–3997greatest surface concentration of O atoms and OH groups
and thus are likely to give the lowest interfacial energy.This journal is © The Royal Society of Chemistry 2015
Fig. 12 Predicted vacuum crystal morphology of FI, with unit cell representation and tabulated data for dominant faces.
Fig. 13 Face indexed crystal of FI from toluene solution, showing
needle growth along the b axis.
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View Article OnlineSolubility and thermodynamic stability relationship
Table 3 presents mean values and standard deviations of trip-
licate measurements of the solubility of FI and FII in five
pure solvents at temperatures between 20 °C and 45 °C. The
standard deviations are relatively small (less than 2.24 × 10−2 g
per 100 g of solvent in all cases) indicating good reproducibility.This journal is © The Royal Society of Chemistry 2015
Fig. 14 Face indexed crystals of FII from acetic acid solution: (a) initially obThe data are represented graphically in Fig. 16, with linear
axis scales, and as a van't Hoff plot in Fig. 17, in which the
logarithm mole fraction solubility, ln xeq, is plotted against
the reciprocal of the absolute temperature.
The mole fraction solubility obtained at different tempera-
tures in each solvent was correlated using eqn (1):
ln xeq = A + B/T (1)
where T is in units of K. The coefficients of eqn (1) obtained
for each solvent by least squares fitting to the mole fraction
solubility data are displayed in Table 4. R2 values for all sys-
tems exceed 0.99.
The apparent or van't Hoff enthalpy of solution38 is essen-
tially constant over the temperature range studied:
solnvH eq/H R
x
T
  d ln
d( )1
(2)
where R is the universal gas constant and the derivative is
the slope of each system obtained from the van't Hoff plot
(Fig. 17), i.e., the regression coefficients B in Table 4. TheCrystEngComm, 2015, 17, 3985–3997 | 3993
served needle and (b) later developed, more prismatic crystal.
Td dT
Td
Fig. 15 The (a) (101), (b) (010) and (c) (10−1) faces of the FII structure.
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View Article Onlinevalues of 
soln
vHH calculated for the two polymorphs in five sol-
vents are given in Table 5.
Overall, mainly as a consequence of the high stability of
the solid phase over the investigated temperature interval,
the solubility is quite low. The highest solubility, expressed
both as mole and mass fractions, is found in toluene,
followed by acetone, acetic acid, acetonitrile and n-butanol.
The solubility of FII is lower than FI, reaffirming the higher
stability of FII over this temperature range. However, careful
examination of the data for the two forms in each solvent
indicates that a transition in thermodynamic stability will
occur not far above the experimental T-range. If eqn (1) and3994 | CrystEngComm, 2015, 17, 3985–3997the coefficients in Table 4 are used for extrapolation of the
solubility data, on average over four solvents, acetic acid, ace-
tone, acetonitrile and n-butanol, the estimated transition
temperature is 64 °C. However, the value obtained from tolu-
ene (249 °C) is quite different from the others, which may be
attributed partly to an increased uncertainty due to the rela-
tively close, parallel solubility curves of FI and FII in this
solvent.
In slurry conversion experiments performed between 30 °C
and 80 °C in the five chosen solvents, the enantiotropic tran-
sition temperature was established to be between 50 °C and
60 °C, below which FII is the stable form. The rate of trans-
formation is low in the vicinity of the transition temperature,
but it could be established that over a period of three weeks a
mixture of FI and FII transformed into FII at 50 °C and into
FI at 60 °C. However, in the absence of FII crystals, the com-
mercial FI exhibited sufficient kinetic stability to retain its
structure over ten days in each of the five evaluated solvents
at three temperatures (25 °C, 35 °C and 50 °C).
Unfortunately, solubility data above the estimated transi-
tion temperature could not be collected. However, assuming
that the linear relationship between solubility and tempera-
ture can be extrapolated up to the transition point, an esti-
mate of the enthalpy and entropy of transition can be
obtained, e.g. according to the method outlined by Svärd
et al.,39 by neglecting the influence of the activity coefficient
on the ratio of solid state activities. The entropy of transfor-
mation can be expressed as:
S
RT
x
x RT x x
II I
eq,II
eq,I eq,II eq,I
d
d 






   
ln
ln ln  (3)where R is the universal gas constant, T is the temperature in
K, and the subscripts correspond to polymorphs I and II.
Inserting eqn (1), we get the following expression for the
entropy of transformation at the transition temperature, Ttr:
S T
RT A A B B
T
R A AII I tr
II I
II I
tr
II I
d
 
  






   ( ) (4)This journal is © The Royal Society of Chemistry 20Eqn (4) shows that the entropy of transformation is indepen-
dent of temperature over the range where solubility curves form
linear van't Hoff plots. At the transition temperature, the Gibbs
energy difference between the polymorphs is zero. With the cal-
culated entropy values, the enthalpy difference can be esti-
mated using eqn (5). The resulting data obtained in four
solvents, using the transition temperatures obtained by extrap-
olation in each solvent, are presented in Table 6. Toluene was
excluded from the analysis for previously outlined reasons.
ΔHII→I(Ttr) = TtrΔS
II→I = RTtr(AII − AI) (5)15
This journal is © The Royal Society of Chemistry 2015
Table 3 Solubility of 1,4-dihydroxyanthraquinone (FI and FII) in five solvents from 20 °C to 45 °C
Solubility of quinizarin FI (standard deviation over three samples) (g per 100 g of solvent)
T/°C Acetic acid Acetone Acetonitrile n-Butanol Toluene
20 0.3036 (0.0004) 0.3986 (0.0045) 0.1924 (0.0033) 0.0768 (0.0046) 1.0968 (0.0044)
25 0.3417 (0.0007) 0.4601 (0.0045) 0.2198 (0.0005) 0.0833 (0.0035) 1.2769 (0.0143)
30 0.4208 (0.0038) 0.5713 (0.0031) 0.2836 (0.0046) 0.1012 (0.0032) 1.4951 (0.0011)
35 0.4912 (0.0044) 0.6865 (0.0045) 0.3433 (0.0063) 0.1169 (0.0054) 1.7583 (0.0049)
40 0.5730 (0.0051) 0.8101 (0.0086) 0.4144 (0.0015) 0.1416 (0.0033) 2.0879 (0.0154)
45 0.6573 (0.0123) 0.9555 (0.0177) 0.4915 (0.0060) 0.1702 (0.0019) 2.4204 (0.0224)
Solubility of quinizarin FII (standard deviation over three samples) (g per 100 g of solvent)
T/°C Acetic acid Acetone Acetonitrile n-Butanol Toluene
20 0.2790 (0.0008) 0.3677 (0.0007) 0.1745 (0.0022) 0.0503 (0.0005) 1.0394 (0.0025)
25 0.3287 (0.0007) 0.4440 (0.0027) 0.2122 (0.0004) 0.0615 (0.0012) 1.2296 (0.0119)
30 0.3854 (0.0068) 0.5350 (0.0003) 0.2638 (0.0015) 0.0776 (0.0005) 1.4601 (0.0084)
35 0.4649 (0.0027) 0.6447 (0.0022) 0.3188 (0.0010) 0.0974 (0.0011) 1.7004 (0.0095)
40 0.5526 (0.0007) 0.7826 (0.0042) 0.3897 (0.0017) 0.1270 (0.0013) 1.9837 (0.0018)
45 0.6540 (0.0011) 0.9341 (0.0023) 0.4752 (0.0008) 0.1580 (0.0005) 2.3399 (0.0115)
Fig. 16 Solubility of quinizarin FI (solid symbols) and FII (hollow
symbols) in: ■, toluene; ▲, acetone; ●, acetic acid; ◆, acetonitrile; and
▼, n-butanol.
Fig. 17 ln xeq of quinizarin FI (solid symbols) and FII (hollow symbols)
vs. 1/T in: ■, toluene; ▲, acetone; ●, acetic acid; ◆, acetonitrile; and ▼,
n-butanol.
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View Article OnlineThe calculations assume that the solubility ratio can
approximate the corresponding activity ratio in all the sol-
vents and that the temperature derivative of the saturated
solution activity coefficients can likewise be neglected. The
lack of consistency in the data obtained in the five solvents
suggests that these assumptions are not well met, especially
not in butanol.CrystEngComm, 2015, 17, 3985–3997 | 3995
Table 6 Entropy and enthalpy of transition at Ttr as estimated from solu-
bility data in four solvents
Solvent Ttr (°C) ΔH
II→I (kJ mol−1) ΔSII→I (J mol−1 K−1)
Acetic acid 55 1.92 5.87
Acetone 65 1.31 3.86
Acetonitrile 87 1.06 2.94
n-Butanol 49 10.70 33.24
Table 5 van't Hoff enthalpy of solution of quinizarin (FI and FII) in five
solvents from 20 °C to 45 °C
Solvent
ΔvHsolnH (kJ mol
−1)
FI FII
Acetic acid 24.6 26.6
Acetone 27.7 29.0
Acetonitrile 30.0 31.1
n-Butanol 25.3 36.0
Toluene 24.6 24.9
Table 4 Solubility regression coefficients (eqn (1)) for FI and FII in five
solvents in the T range of 20 °C to 45 °C
Solvent
FI FII
A B A B
Acetic acid 2.9110 −2964.6 3.6166 −3195.7
Acetone 4.3868 −3327.4 4.8512 −3484.5
Acetonitrile 4.2780 −3613.4 4.6314 −3740.3
n-Butanol 1.9620 −3037.6 5.9597 −4327.7
Toluene 4.6154 −2961.9 4.6699 −2990.4
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View Article OnlineThe quinizarin molecule contains the fully conjugated
cyclic dione structure embedded as in the 9,10-anthraquinone
structure. The two ketone groups are, in principle, hydrogen
bond accepting. In quinizarin, there are, in addition to
the anthraquinone structure, two alcohol groups in
para-position, and these have hydrogen bond accepting as
well as donating functionality. However, the proximity of
each ketone group with each respective alcohol group leads
to intra-molecular hydrogen bonding, reducing the inter-
molecular hydrogen bond accepting functionality of the
ketone groups and the hydrogen bond donating capability of
the alcohol groups. Obviously, solvation of the hydrophobic
parts of the molecule plays an important role for the solubil-
ity and should explain why the solubility is highest in tolu-
ene. The results further show that the hydrogen bonding of
acetone and acetonitrile to the alcohol groups of quinizarin
does not sufficiently compensate for the lower capability of
these solvents of solvating the hydrophobic part. n-Butanol
is able to hydrogen bond to the ketones as well as to the
alcohol groups, but in spite of this, the solubility in this sol-
vent is the lowest. The acetic acid solubility is at first sur-
prising. Of course, acetic acid has the capability to hydrogen
bond to both the ketone groups and the alcohol groups, but
in fact the strongest bonding is expected to occur as dimer-
ization of two acetic acid molecules. Perhaps this dimeriza-
tion actually provides acetic acid with a greater capability to
solvate the hydrophobic parts of the quinizarin molecule.
Single acetic acid molecules can hydrogen bond to the polar
parts of the molecule, while dimers can solvate the hydro-
phobic parts.Conclusions
The crystal structure of FII has been solved and a high-
temperature polymorph of quinizarin (FIII) has been
detected using DSC and HT-XRD. An attempt to index FIII
PXRD data at 180 °C yielded a triclinic P1¯ cell and a Le Bail
analysis confirmed the match of the cell to experimental
data. The influence of solvent on crystal morphology and
polymorphic form has been investigated by slow evaporation
and cooling experiments, and there are no distinguishing
shape differences between FI and FII. The solubility of
quinizarin FI and FII in organic solvents decreases in the
order: toluene, acetone, acetic acid, acetonitrile and
n-butanol while no solvates were found. The solubility is
overall low, below 2.5% by weight, over the range of condi-
tions of this work. All van't Hoff curves are approximately lin-
ear over the investigated temperature interval. There is an
enantiotropic relationship between FI and FII with a transi-
tion temperature experimentally determined to be between
50 °C and 60 °C. The commercial solid FI is found to be
metastable in relation to FII below the transition tempera-
ture. However, at ambient temperature and in the five sol-
vents investigated, the transformation in the absence of FII
is slow, requiring many days.3996 | CrystEngComm, 2015, 17, 3985–3997Acknowledgements
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